Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
11/2002
11/07/2002US20020165361 Antibody for use in the diagnosis and treatment of cell proliferation disorders
11/07/2002US20020165347 Polypeptide for use in the diagnosis, prevention and treatment of arteriosclerosis and vascular restenosis
11/07/2002US20020165249 Nasal delivery of apomorphine
11/07/2002US20020165209 Low dose estrogen interrupted hormone replacement therapy
11/07/2002US20020165190 Expression vector coding p972 gene for cancer therapy and adenovirus producing the same
11/07/2002US20020165131 Histidine-rich glycoprotein
11/07/2002US20020164767 DNA encoding the human serine protease C-E
11/07/2002US20020164714 Nucleotie sequences coding polypeptide for use in the treatment of reproductive disorders
11/07/2002US20020164707 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, arthrits, pain, diabetes, migraine and inflammation, hypercalcemia, obesity, hypertension, and bone defects
11/07/2002US20020164331 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
11/07/2002US20020164312 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/07/2002US20020164287 Azo compounds for type i phototherapy
11/07/2002CA2446514A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002CA2446052A1 Compositions and methods for treating vulvovaginitis and vaginosis
11/07/2002CA2445859A1 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene
11/07/2002CA2445702A1 Control of compactability through crystallization
11/07/2002CA2445583A1 Antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7h-[1,4]dioxino[2,3-e]indole
11/07/2002CA2445581A1 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoxaline
11/07/2002CA2445565A1 Compositions and methods of double-targeting virus infections and cancer cells
11/07/2002CA2445552A1 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta[a]naphthalene
11/07/2002CA2445543A1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-¬1,4|-benzodioxans
11/07/2002CA2445410A1 Ovary-specific genes and proteins
11/07/2002CA2445343A1 Use of protein and essential amino acids to treat amenorrhea and related disorders
11/07/2002CA2445338A1 G-protein coupled receptors
11/07/2002CA2445290A1 A pharmaceutical tablet having a high api content
11/07/2002CA2439943A1 Benzimidazoles that are useful in treating sexual dysfunction
11/06/2002EP1254905A1 4-(2-Pyridyl)piperazines having 5HT7 receptor agonist activity
11/06/2002EP1254662A2 Methods and kits for treating depression or preventing deterioration of cognitive function
11/06/2002EP1254255A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies
11/06/2002EP1254242A1 17 human secreted proteins
11/06/2002EP1254236A2 Drug metabolizing enzymes
11/06/2002EP1254235A2 Drug metabolizing enzymes
11/06/2002EP1254222A1 Human gaba receptor proteins and polynucleotides encoding the same
11/06/2002EP1254220A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same
11/06/2002EP1254214A2 Human protein kinases and protein kinase-like enzymes
11/06/2002EP1254212A2 Methods of preparing and using a viral vector library
11/06/2002EP1254175A1 Human cystine knot polypeptide
11/06/2002EP1254143A2 Lipid-based drug delivery systems
11/06/2002EP1254138A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
11/06/2002EP1254134A2 1,3-dihydro-2h-indol-2-one derivatives,and their use as ligands for v1b or v1b and v1a arginine-vasopressin-receptors
11/06/2002EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002EP1254114A2 Melanocortin receptor agonists and antagonists
11/06/2002EP1253926A1 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
11/06/2002EP1253916A1 Method of treating vaginal dryness with nicotinic acetylcholine receptor agonists
11/06/2002EP0981349B1 5-alpha-pregnan-3-beta-ol-20-one sulfate for the treatment of tumours and cns diseases
11/06/2002EP0981327B1 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
11/06/2002EP0781280B1 Derivatives of benzopyran and of benzothiopyran, their preparation and their use as agonists of dopaminergic receptors
11/06/2002EP0639970B2 Contraception method using competitive progesterone antagonists and novel compounds useful therein
11/06/2002CN1378551A 嘌呤衍生物 Purine derivatives
11/06/2002CN1378547A 5-(2-substituted-5-heterocyclylsulphenylpyrid-3-yl)-dihydropyrazolo [4,3-d] pyrimidin 7-ones as phosphodiesterase inhibitors
11/06/2002CN1378535A 四氢喹啉衍生物 Tetrahydroquinoline derivative
11/06/2002CN1378532A Substituted 1,5-dihydropyrrol-2-on derivatives as NMDA receptor antagonists for treatment of pain
11/06/2002CN1378531A Substituted pyrolidine-2,3,4-trion-3-oxime derivatives useful as NMDA receptor antagonists
11/06/2002CN1378527A Biaryl ether derivatives useful as monoamine reuptake inhibitors
11/06/2002CN1378455A Use of diterpenoid triepoxides as anti-proliferative agent
11/06/2002CN1377889A Protein for causing sperm not wandering prepared from india worm lizard body cavity liquid
11/06/2002CN1377703A Medicine for artificially inducing rockfish's sex reversion and preparing method and use
11/06/2002CN1377698A Nano woman's cleaning and nursing aloe lotion and its preparing method
11/06/2002CN1377670A Long life tea for curing various diseases
11/06/2002CN1093764C Medical liquor for nourishing kindney
11/05/2002US6476079 Devices for the delivery of drugs having antiprogestinic properties
11/05/2002US6476078 Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
11/05/2002US6476074 Method and composition for treatment of erectile dysfunction
11/05/2002US6476038 Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
11/05/2002US6476037 L-arginine and phosphodiesterase (PDE) inhibitor synergism
11/05/2002US6476029 7-alkyl- and cycloalkyl-substituted imidazotriazinones
11/05/2002US6476025 Phenylphennanthridines with PDE-IV inhibiting activity
11/05/2002US6476022 Oxathiepino[6,5-b]dihydropyridines, and related compositions and methods
11/05/2002US6475997 Methods of stimulating phagocytosis
11/05/2002US6475493 Controlled release pellet formulation
11/05/2002CA2038379C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
11/02/2002CA2384344A1 4-(2-pyridyl)piperizines having 5ht7 receptor agonist activity
10/2002
10/31/2002WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
10/31/2002WO2002086078A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
10/31/2002WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002WO2002085930A2 Immunomodulating agents from parasitic worms and method for isolation thereof
10/31/2002WO2002085925A2 Melanocortin receptor ligands
10/31/2002WO2002085907A1 Novel 3-c(o)r substituted 10-cyclohexylbenzoyl pyrrolobenzodiazepines; tocolytic oxytocin receptor antagonists
10/31/2002WO2002085906A2 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002WO2002085897A1 Heterocyclic compounds for aging-related and diabetic vascular complications
10/31/2002WO2002085894A1 Arylindenopyridines with pde inhibiting activity
10/31/2002WO2002085868A1 Benzoxazinone derivatives for use in the treatment of angiogenesis
10/31/2002WO2002085859A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
10/31/2002WO2002085839A1 Fused bicyclic or tricyclic amino acids
10/31/2002WO2002085399A1 Peptide-containing preparations
10/31/2002WO2002085393A1 Hop extracts and use thereof in the production of a medicament having estrogenic properties
10/31/2002WO2002085392A1 Method for using puerariae radix, puerariae radix flavone extract and preparation containing puerarin in the prevention and treatment of new indications
10/31/2002WO2002085387A2 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent ans their use in the treatment of inflammatory skin conditions
10/31/2002WO2002085386A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
10/31/2002WO2002085385A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa
10/31/2002WO2002085384A2 Lubricious coatings for substrates
10/31/2002WO2002085375A1 Novel hormone composition
10/31/2002WO2002085336A1 Orodispersible effervescent tablets
10/31/2002WO2002085299A2 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/31/2002WO2002070565A9 High-affinity antagonists of elr-cxc chemokines
10/31/2002WO2002049650A3 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
10/31/2002WO2002041896A3 Use of thienopyrimidines
10/31/2002WO2002032283A3 Methods of and pharmaceutical compositions for improving implantation of embryos
10/31/2002WO2001061356A9 Her-2 binding antagonists
10/31/2002WO2001044243A3 Novel heteroaryl-diazabicycloalkanes
1 ... 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 ... 557